Related Experiment Videos
Internal mammary artery bypass graft in reoperative myocardioal revascularization
Insights
Internal mammary artery grafts offer a valuable alternative for repeat coronary artery bypass grafting, showing high patency rates and positive patient outcomes in reoperation cases.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Vascular Surgery
Background:
- Repeat coronary artery bypass grafting (CABG) is complex, often necessitated by graft failure or disease progression.
- Internal mammary artery (IMA) grafts are increasingly considered for reoperations due to their durability.
- Patient selection and surgical technique are critical for successful reoperative CABG.
Purpose of the Study:
- To evaluate the efficacy and safety of using internal mammary artery grafts in patients undergoing reoperation for coronary artery disease.
- To assess graft patency and clinical outcomes following reoperative myocardial revascularization with IMA grafts.
Main Methods:
- Retrospective analysis of 32 consecutive patients undergoing reoperative CABG.
- Utilized internal mammary artery grafts, alone or with saphenous vein grafts.
- Performed graft construction under normothermic perfusion with anoxic arrest and interrupted suture technique.
Main Results:
- No intraoperative myocardial infarctions or hospital deaths were observed.
- All patients survived the 20-month average follow-up period, with two-thirds remaining asymptomatic.
- Post-reoperation arteriography in nine patients showed 89% patency for IMA grafts and 100% for secondary vein grafts.
Conclusions:
- Internal mammary artery bypass grafting is a safe and effective option for reoperative myocardial revascularization.
- IMA grafts demonstrate excellent patency and contribute to favorable long-term outcomes in patients with prior graft failure or small coronary vessels.
Abstract:
Thirty-two consecutive patients who earlier received indirect or direct myocardial revascularization underwent reoperation with one or more internal mammary artery grafts either alone or in combination with saphenous vein grafts. The main indication for reoperation was graft closure or progression of coronary atherosclerosis in nongrafted vessels, or both. Graft construction was performed under normothermic perfusion and anoxic arrest with interrupted suture technique. No intraoperative infarctions or hospital deaths occurred. All patients are alive after an average follow-up period of 20 months, and two thirds are asymptomatic. Arteriography after reoperation in nine patients revealed patency of eight of nine internal mammary artery and five of five secondary vein grafts. When angiographic and symptomatic indications for reoperation exist, the internal mammary artery bypass graft has become a valuable alternative, particularly for patients with small coronary vessels or previous vein graft failure.